RUNX1 and acute myeloid leukemia: Experiments with LCs from these mice showed that knock-down of Evi1 per se reduced LSCe/LSC abundance, quiescence, and activity (the first demonstration of a key role of Evi1 in AML LSCs), and additionally abolished the stemness promoting effects of atRA [17].